Bevacizumab
3066K1-3311
Phase 3 small_molecule completed
Quick answer
Bevacizumab for Renal Cell Carcinoma is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Renal Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed